Brian Intoccia
About Brian Intoccia
Brian Intoccia is the Managing Director of Consulting at Enzyme, specializing in the medical device and biopharma industries with a strong background in product development and quality assurance.
Managing Director at Enzyme
Brian Intoccia serves as the Managing Director of Consulting at Enzyme, a position he has held since joining the company in 2020. At Enzyme, he leads consulting practices focused on delivering strategic solutions and expert guidance for medical device and biopharma companies. His role involves overseeing the consulting team and ensuring the successful execution of client projects and initiatives.
Experience in Medical Device and Biopharma Industry
Brian Intoccia brings 15 years of experience in the medical device and biopharma industry. His extensive background includes working on the development of Class II & III medical devices and drug-device combination products. Intoccia has contributed to the launch of these products at reputable companies such as Amgen, Medtronic, and Boston Scientific. His involvement ranges from early-stage development to ensuring product compliance and successful market introduction.
Expertise in Medical Device Product Development
With a strong background in the medical device product development process, Brian Intoccia is well-versed in design assurance and systems engineering. He has played a pivotal role in guiding the development of various medical devices, ensuring they meet stringent regulatory standards and achieve commercial success. His expertise covers both hardware and software aspects of medical devices, including SaMD, capital equipment, and disposables.
Consultation for Biopharma Industry Leaders
Before his current role at Enzyme, Brian Intoccia was a trusted consultant for leading biopharma companies such as Amgen, Sanofi, Regeneron, and Eli Lilly. His consultancy work involved offering strategic insights and operational support in areas like quality assurance, program development, and team development. His deep understanding of both the biopharma and medical device sectors allows him to provide comprehensive solutions tailored to each client's specific needs.